SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PHP Healthcare
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DENNIS DOCKERY who wrote (63)7/27/1998 5:31:00 PM
From: Jim Mac   of 136
 
I think only 3M common will be added by remaining preferred conversions, and PHP may already have removed 3M common from market by now, thanks to these low prices. Therefore, no dilution.

Looks like future quarterly operating cash flow of $10M more or less, even with paying down that HIP medical claims payable over 4 quarters. Increasing claims payable in January quarter was a good move, since it allowed PHP to put more cash to work streamlining HIP clinics and lowering medical expense ratios during first 90 days of operation, which will increase future cash flow.

Investing and financing cash flows should be minor, giving overall good cash flow. Any buyback debt repayment should be no problem with all the cash flow being generated, or can be largely covered by a million common issue later on (assuming higher PPH). In either event, it may be able to get renegotiated.

I see no problems.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News